Arkema S.A./€AKE
1D1W1MYTD1Y5YMAX
Capital at risk
About Arkema S.A.
Arkema S.A. is a global chemicals company headquartered in Colombes, France. It operates in the specialty chemicals and materials industry, focusing on the production of advanced materials, adhesives, and coatings. The company segments its operations into three main areas: High-Performance Materials, Industrial Specialties, and Coating Solutions, catering to sectors such as automotive, construction, and electronics. Founded in 2004 as a spin-off from TotalEnergies, Arkema has developed a significant international presence with operations across Europe, North America, and Asia. Its strategic positioning is underscored by ongoing investments in innovation and sustainable development, aimed at meeting diverse industrial needs. Sources:
Arkema official website
Arkema annual reports and investor relations materials
- Ticker
- €AKE
- Sector
- Materials
- Primary listing
- PAR
- Employees
- 20,648
- Headquarters
- Puteaux, France
- Website
- www.arkema.com
Arkema S.A. Metrics
BasicAdvanced
€4.3B
-
-€0.07
0.96
€3.60
6.31%
Price and volume
Market cap
€4.3B
Beta
0.96
52-week high
€67.00
52-week low
€45.50
Average daily volume
146K
Dividend rate
€3.60
Financial strength
Current ratio
1.518
Quick ratio
1.069
Long term debt to equity
0.417
Total debt to equity
0.614
Dividend payout ratio (TTM)
527.23%
Interest coverage (TTM)
4.58%
Profitability
EBITDA (TTM)
1,139.4
Gross margin (TTM)
17.83%
Net profit margin (TTM)
0.67%
Operating margin (TTM)
5.07%
Effective tax rate (TTM)
59.29%
Revenue per employee (TTM)
€430,000
Management effectiveness
Return on assets (TTM)
2.01%
Return on equity (TTM)
0.86%
Valuation
Price to revenue (TTM)
0.484
Price to book
0.72
Price to tangible book (TTM)
4.27
Price to free cash flow (TTM)
12.236
Free cash flow yield (TTM)
8.17%
Free cash flow per share (TTM)
4.665
Dividend yield (TTM)
6.31%
Forward dividend yield
6.31%
Growth
Revenue change (TTM)
-5.74%
Earnings per share change (TTM)
-90.08%
3-year revenue growth (CAGR)
-5.19%
10-year revenue growth (CAGR)
1.66%
3-year earnings per share growth (CAGR)
-78.39%
10-year earnings per share growth (CAGR)
-25.81%
3-year dividend per share growth (CAGR)
1.92%
10-year dividend per share growth (CAGR)
6.60%
Bulls say / Bears say
Q2 2026 EBITDA increased 7.4% year over year to €391 million, lifting the EBITDA margin to 16.1%; Arkema also reaffirmed its expectation for slightly higher full-year 2026 EBITDA at constant exchange rates. (Arkema)
Major growth projects are beginning to contribute: Arkema expects around €50 million of additional EBITDA in 2026 versus 2025, alongside the ramp-up of its Dow adhesives acquisition, Singapore PA11 and Rilsan Clear plants, and U.S. PVDF expansion. (Arkema)
Exposure to attractive specialty-materials markets remains a strength, with batteries, electronics and 3D printing continuing to provide meaningful growth; Asia, especially Southeast Asia and India, also showed good momentum in Q2. (Arkema)
Global demand remains weak, with continued challenges in Europe—particularly France and Germany—and weaker Performance Additives weighing on Advanced Materials. (Arkema)
Arkema faced a sharp increase in raw-material costs following Middle East conflict developments, while supply-chain disruption and a €10 million foreign-exchange headwind pressured profitability. (Arkema)
Balance-sheet and execution risks remain material: net debt was approximately €3.6 billion after the dividend, while recurring cash flow was only €78 million in Q2 and 2026 capital expenditure is planned at roughly €600 million. (Arkema)
Data summarised monthly by Lightyear AI. Last updated on 9 Sept 2026.
Upcoming events
No upcoming events
Funds containing Arkema S.A.
AllEURGBPUSD
Fund name | Fund size | €AKE weighting |
|---|---|---|
iShares STOXX Europe 600 Chemicals€EXV7 | €104M | 1.81% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.24% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.24% |
L&G Global Quality Dividends£LDGG | £279M | 0.07% |
iShares EURO STOXX€SXXEEX | €2.9B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.